Thanks, Pete. I'll provide a brief overview and, of course, welcome all of you to review our filings in greater detail or reach out to our team with questions you may have.
Before I get started, I wanted to highlight the adoption of recent accounting guidance, which we believe enhances the usefulness of our financial reporting. We adopted ASU 2020-06 on July 1, 2021. Among other changes, this ASU simplifies the accounting for convertible instruments by eliminating the separation of the cash conversion feature on our convertible notes that were issued in February 2020.
Under the full retrospective method of adoption, we have recast our previously reported financial information in accordance with the new standard, which eliminated approximately $700,000 in annual noncash interest expense and improves the usefulness of our financial statements. The footnotes in our recently filed Form 10-Q provide additional information on this accounting change.
Moving on to our results. During the quarter ended September 30, 2021, we reported consolidated revenue of $16.5 million, net income from continuing operations of $0.1 million and adjusted EBITDA of $4.3 million. For the same period last year, we reported consolidated revenue of $15.4 million, net loss from continuing operations of $3.8 million and adjusted EBITDA of $1.9 million.
Great Elm reports the results of each of our 2 operating segments, including operating companies and investment management as well as unallocated General Corporate activity. We'll begin the review with operating companies. For the fiscal first quarter, DME generated $15.6 million in revenue compared to $14.6 million for the same period last year. The increase in revenues was driven by strong and continued organic growth in resupply sales as well as some contributions from recent acquisitions AMPM and MedOne.
Great Elm's DME operations reported net income of $2.1 million in comparison to a net loss of $0.5 million in the prior year period. This comparison is impacted by $2.3 million in employee retention credits claimed under the CARES Act during the current quarter, whereas no CARES Act stimulus was received in the prior comparable quarter. In addition, gross margins increased due to favorable sales mix, vendor pricing and efficiency initiatives. Adjusted EBITDA was $5.1 million compared to $2.8 million in the same period last year.
Next, turning to investment management. For the fiscal first quarter, investment management reported total revenue of $1.0 million compared to $0.8 million during the same period in the prior year. Revenue for the quarter was slightly higher due to increases in the average assets on which such fees are calculated. Adjusted EBITDA was $0.1 million in the fiscal 2022 first quarter compared to $0.2 million during the same period in the prior year. Adjusted EBITDA for the quarter was impacted primarily by increased employee-related costs and professional fees related to investment management growth initiatives.
Moving on to our General Corporate segment. For the fiscal first quarter, Great Elm's General Corporate segment recognized $0.2 million in revenue compared to $0.1 million in revenue during the same period in the prior year. Revenue increased as a result of increased management fees earned from DME, along with management fees earned from GEG's majority-owned subsidiary, Forest Investments, Inc. under a management agreement that was put into place in connection with the JPMorgan financing transactions in December 2020.
General Corporate adjusted EBITDA for the current quarter was negative $1.0 million compared to negative $1.1 million during the same period in the prior year. Great Elm continues to focus on rationalizing our corporate overhead to put us in the best position to execute our strategy. We ended the quarter with a healthy liquidity position, including $21.8 million in cash.
This concludes my financial review of the quarter, and I'll turn it back to Pete for closing remarks.